The Current Ratio as of October 2024 (TTM) for Genetic Technologies Limited (GENE) is 0.88

According to Genetic Technologies Limited’s latest financial reports and current stock price. The company's current Current Ratio is 0.88. This represents a change of -30.95% compared to the average of 1.28 of the last 4 quarters.

Genetic Technologies Limited (GENE) Historical Current Ratio (quarterly & annually)

How has GENE Current Ratio performed in the past?

The mean historical Current Ratio of Genetic Technologies Limited over the last ten years is 6.92. The current 0.88 Current Ratio has changed 1.17% with respect to the historical average. Over the past ten years (40 quarters), GENE's Current Ratio was at its highest in in the March 2021 quarter at 15.82. The Current Ratio was at its lowest in in the March 2024 quarter at 0.88.

Genetic Technologies Limited (GENE) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Genetic Technologies Limited Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Genetic Technologies Limited (GENE) Average Current Ratio

How has GENE Current Ratio performed in the past?

The current Current Ratio of Genetic Technologies Limited (GENE) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Genetic Technologies Limited (GENE) Current Ratio vs. Peers

How is GENE’s Current Ratio compared to its peers?

Genetic Technologies Limited’s Current Ratio is less than Biocept, Inc. (1.81), greater than T2 Biosystems, Inc. (0.60), less than HTG Molecular Diagnostics, Inc. (1.40), less than Intelligent Bio Solutions Inc. (1.57), greater than Interpace Biosciences, Inc. (0.53), less than bioAffinity Technologies, Inc. (1.15), less than SeqLL Inc. (1.06), less than Agilent Technologies, Inc. (1.78), less than Sera Prognostics, Inc. (0), less than Precipio, Inc. (2.08), greater than MDxHealth SA (0.73), less than null (0.91),

Build a custom stock screener for Genetic Technologies Limited (GENE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Genetic Technologies Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Genetic Technologies Limited (GENE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Genetic Technologies Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.